Antiendothelial Cell Antibodies

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Antiendothelial cell antibodies (AECA) are a family of autoantibodies able to react with endothelial cells (EC), which differ from each other for antigen specificity, ability to bind to surface or intracellular structures, and functional effects. Natural AECA exist, display in vitro anti-inflammatory action on EC, and probably contribute to the therapeutic activity of high-dose intravenous immunoglobulins (IVIG) in several systemic inflammatory disorders. Pathologic AECA are produced in abnormal amount and composition during many diseases associated with endothelial perturbation. Various assays have been developed to detect and study pathologic AECA for both clinical and experimental investigations. The pathogenic role of AECA is suggested by both experimental evidence and clinical data: AECA are able to induce proinflammatory and procoagulant properties in EC and to cause various disease manifestations in animal models. AECA prevalence and specificity seem to be specific for the single diseases and their circulating levels sometimes vary with disease activity. The identification of antigens recognized in single diseases is crucial to improve diagnostic and prognostic relevance of AECA detection and obtain detailed information on their mechanisms of action.

Original languageEnglish
Title of host publicationAutoantibodies: Third Edition
PublisherElsevier B.V.
Pages723-729
Number of pages7
ISBN (Print)9780444563781
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Endothelial Cells
Antigens
Antibody Specificity
anti-endothelial cell antibody
Intravenous Immunoglobulins
Autoantibodies
Anti-Inflammatory Agents
Animal Models
Therapeutics
In Vitro Techniques

Keywords

  • AECA antigens
  • AECA assays
  • Antiendothelial antibodies
  • Natural AECA
  • Pathogenic AECA

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Cite this

Antiendothelial Cell Antibodies. / Ronda, Nicoletta; Raschi, Elena; Borghi, Maria O.; Meroni, Pier Luigi.

Autoantibodies: Third Edition. Elsevier B.V., 2013. p. 723-729.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ronda, N, Raschi, E, Borghi, MO & Meroni, PL 2013, Antiendothelial Cell Antibodies. in Autoantibodies: Third Edition. Elsevier B.V., pp. 723-729. https://doi.org/10.1016/B978-0-444-56378-1.00085-X
Ronda N, Raschi E, Borghi MO, Meroni PL. Antiendothelial Cell Antibodies. In Autoantibodies: Third Edition. Elsevier B.V. 2013. p. 723-729 https://doi.org/10.1016/B978-0-444-56378-1.00085-X
Ronda, Nicoletta ; Raschi, Elena ; Borghi, Maria O. ; Meroni, Pier Luigi. / Antiendothelial Cell Antibodies. Autoantibodies: Third Edition. Elsevier B.V., 2013. pp. 723-729
@inbook{58ceb60254e4410baeb543844949ccea,
title = "Antiendothelial Cell Antibodies",
abstract = "Antiendothelial cell antibodies (AECA) are a family of autoantibodies able to react with endothelial cells (EC), which differ from each other for antigen specificity, ability to bind to surface or intracellular structures, and functional effects. Natural AECA exist, display in vitro anti-inflammatory action on EC, and probably contribute to the therapeutic activity of high-dose intravenous immunoglobulins (IVIG) in several systemic inflammatory disorders. Pathologic AECA are produced in abnormal amount and composition during many diseases associated with endothelial perturbation. Various assays have been developed to detect and study pathologic AECA for both clinical and experimental investigations. The pathogenic role of AECA is suggested by both experimental evidence and clinical data: AECA are able to induce proinflammatory and procoagulant properties in EC and to cause various disease manifestations in animal models. AECA prevalence and specificity seem to be specific for the single diseases and their circulating levels sometimes vary with disease activity. The identification of antigens recognized in single diseases is crucial to improve diagnostic and prognostic relevance of AECA detection and obtain detailed information on their mechanisms of action.",
keywords = "AECA antigens, AECA assays, Antiendothelial antibodies, Natural AECA, Pathogenic AECA",
author = "Nicoletta Ronda and Elena Raschi and Borghi, {Maria O.} and Meroni, {Pier Luigi}",
year = "2013",
month = "12",
doi = "10.1016/B978-0-444-56378-1.00085-X",
language = "English",
isbn = "9780444563781",
pages = "723--729",
booktitle = "Autoantibodies: Third Edition",
publisher = "Elsevier B.V.",

}

TY - CHAP

T1 - Antiendothelial Cell Antibodies

AU - Ronda, Nicoletta

AU - Raschi, Elena

AU - Borghi, Maria O.

AU - Meroni, Pier Luigi

PY - 2013/12

Y1 - 2013/12

N2 - Antiendothelial cell antibodies (AECA) are a family of autoantibodies able to react with endothelial cells (EC), which differ from each other for antigen specificity, ability to bind to surface or intracellular structures, and functional effects. Natural AECA exist, display in vitro anti-inflammatory action on EC, and probably contribute to the therapeutic activity of high-dose intravenous immunoglobulins (IVIG) in several systemic inflammatory disorders. Pathologic AECA are produced in abnormal amount and composition during many diseases associated with endothelial perturbation. Various assays have been developed to detect and study pathologic AECA for both clinical and experimental investigations. The pathogenic role of AECA is suggested by both experimental evidence and clinical data: AECA are able to induce proinflammatory and procoagulant properties in EC and to cause various disease manifestations in animal models. AECA prevalence and specificity seem to be specific for the single diseases and their circulating levels sometimes vary with disease activity. The identification of antigens recognized in single diseases is crucial to improve diagnostic and prognostic relevance of AECA detection and obtain detailed information on their mechanisms of action.

AB - Antiendothelial cell antibodies (AECA) are a family of autoantibodies able to react with endothelial cells (EC), which differ from each other for antigen specificity, ability to bind to surface or intracellular structures, and functional effects. Natural AECA exist, display in vitro anti-inflammatory action on EC, and probably contribute to the therapeutic activity of high-dose intravenous immunoglobulins (IVIG) in several systemic inflammatory disorders. Pathologic AECA are produced in abnormal amount and composition during many diseases associated with endothelial perturbation. Various assays have been developed to detect and study pathologic AECA for both clinical and experimental investigations. The pathogenic role of AECA is suggested by both experimental evidence and clinical data: AECA are able to induce proinflammatory and procoagulant properties in EC and to cause various disease manifestations in animal models. AECA prevalence and specificity seem to be specific for the single diseases and their circulating levels sometimes vary with disease activity. The identification of antigens recognized in single diseases is crucial to improve diagnostic and prognostic relevance of AECA detection and obtain detailed information on their mechanisms of action.

KW - AECA antigens

KW - AECA assays

KW - Antiendothelial antibodies

KW - Natural AECA

KW - Pathogenic AECA

UR - http://www.scopus.com/inward/record.url?scp=84902070303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902070303&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-56378-1.00085-X

DO - 10.1016/B978-0-444-56378-1.00085-X

M3 - Chapter

AN - SCOPUS:84902070303

SN - 9780444563781

SP - 723

EP - 729

BT - Autoantibodies: Third Edition

PB - Elsevier B.V.

ER -